Quantitative stereologic analyses were conducted on hematoxylin and eosin-stained liver sections to investigate the potential effects of the presence of mononuclear cell leukemia in Fischer 344 rats on the occurrence of altered hepatocellular foci (AHF). The study consisted of 132 male and 144 female rats taken from control groups at the termination of seven, 2-year National Toxicology Program (NTP) carcinogenicity studies. A minimum of 10 male and 10 female rats were killed at 6, 9, 12, 15, and 18 months into the seven NTP studies to assess progressive development of AHF. At the end of the studies, 43 males and 35 females had histologic evidence of mononuclear cell leukemia in the liver. There were no differences in the morphologic features of AHF between leukemic and non-leukemic rats; however, there was a decreased incidence of clear AHF in both sexes and in basophilic, vacuolated, and mixed-cell AHF in males. Stereologic analysis revealed that there was also a 40 to 73% reduction in the density of basophilic, clear, vacuolated, and mixed-cell AHF in male rats with leukemia and a 3 1 and 70% reduction in basophilic and clear AHF, respectively, in females with leukemia. The number of eosinophilic AHF was statistically unchanged in both sexes. The eosinophilic AHF, however, were 2.3 times larger and occupied a 4.3-fold greater volume fraction of the liver in leukemic male rats. Changes in the incidence and density ofAHF were directly associated with the severity of the leukemia. It is postulated that the high incidence of spontaneous mononuclear cell leukemia in carcinogenicity studies using Fischer 344 rats may cause the regression of most types of AHF, may coincidentally provide a selective growth advantage for eosinophilic AHF in male rats, and may make the determination of a weak hepatocarcinogenic effect more difficult.
Administration of hepatocarcinogenic agents to rats initially results in induction of phenotypically altered hepatocellular foci (AHF) that may subsequently develop into benign or malignant hepatocellular neop l a s m~.~,~,~,~~,~~ AHF are believed to be clonally expanded populations of carcinogen-initiated hepatocytes and are considered "preneoplastic" lesions by some investigators. 1,7, 39 While the evidence for progressive development of AHF to benign and ultimately malignant neoplasms is indirect, it has recently been suggested that the induction of AHF be considered in regulatory deci~ion-making.~~ More recently; mediumterm rat model systems that use AHF as an endpoint have been proposed as "bioassays" for assessing the hepatocarcinogenic potential of chemical agents. 35 There is still controversy, however, about the biological significance of AHF. In some protocols where exposure to the potential carcinogenic agent is discontinued early in the experiment, there is reversion or "remodeling" of all or most AHF, and even larger proliferative nodules, back to a "normal" morphologic appearance.3,4J0,26-29,37,40 Thus, some investigators have questioned the relevance of AHF in the process of hepatocarcin~genesis.~~.~~ Study of potential factors that may affect the induction, stability, and persistence of AHF should help in an understanding of the biological significance of these lesions. The observed inverse relationship between leukemia and hepatocarcinogenesis in r o d e n t~'~,~~ prompted the present investigation. The purpose of this study was to investigate the effect of concomitant leukemia on putative preneoplastic AHF.
Materials and Methods
Material evaluated in this study was obtained from control Fischer 344 rats of both sexes used in 2-year National Toxicology Program (NTP) toxicity and carcinogenicity studies of talc, methyl carbamate, C.I. Acid Red 114, epinephrine hydrochloride, 4-hydroxyacetanilide, l-amino-2,4-dibromoanthraquinone, and dimethoxane. These seven NTP studies were conducted between 1981 and 1986. During this interval there was no evidence of genetic drift or other differences in the lots of rats used in the seven NTP studies, and laboratory conditions were essentially identical among the studies. t Significantly different from non-leukemic rats (P < 0.01).
For the present investigation, 132 male and 144 female rats were used. Their altered hepatocellular foci (AHF) were subjected to stereologic analysis 24 months into the studies. These rats included 43 males and 35 females with histologic evidence of mononuclear cell leukemia in the liver (Table  1) . To show the progressive development of AHF over time, stereologic data on AHF in non-leukemic rats were obtained from a minimum of 10 males and 10 females at several time points (see Fig. 1 ) prior to the 24-month termination of the seven NTP studies.
Liver sections, approximately 6 microns thick, were prepared from original paraffin blocks containing the left and median or right liver lobes (all studies included the left lobe but the second lobe varied between laboratories). For consistency, all paraffin sections were stained with hematoxylin and eosin at the same laboratory.
The leukemic rats were characterized as having minimal (l+), mild (2+), or moderate (3+) leukemia based on the severity of leukemic cell infiltration in the liver. Minimal (1 +) leukemia was characterized by the presence of a few mononuclear cells in some of the hepatic sinusoids as detected under 400 x magnification. Moderate (3 +) leukemia was readily observed under 200x magnification and consisted of numerous leukemic cells in almost all hepatic sinusoids but without morphologic evidence of secondary changes, such as atrophy or degeneration, in the hepatocytes. Mild (2+) leukemia represented a severity of mononuclear cell infiltration between 1 + and 3 +. Rats with severe (4+) leukemia had massive hepatic infiltration with histologic evidence of hepatocyte degeneration and atrophy and were not used in the present investigation because of potential difficulty in identifying AHF. Observation of proliferative leukemic cells in the splenic red pulp confirmed all cases of leukemia. No other hepatic lesions were present in any of the livers that might influence the development or recognition of AHF. The incidence of mononuclear cell leukemia in control rats in the seven NTP studies was within expected ranges.
Each focus found in the hematoxylin and eosin-stained sections was classified into one of the following five categories using previously published criteria: 1.2.5.9.14.17.20.25. 33 basophilic, eosinophilic, clear, vacuolated, and mixed-cell foci. If a given cell type occupied more than 70% of a focus with multiple cell types, then that focus was classified by the predominant cell type. When two or more cell types were present and each occupied less than 70% of the focus, then that focus was classified as mixed. Quantitative measurements of total area of liver sections and area of each focus were made using appropriate magnification (12.8 to 320x for foci), using a computer-assisted image analyzer (Optomax, Inc., Burlington, MA) interfaced with a camera lucida. Areas occupied by any tumors, large blood vessels and/or cysts more than one square millimeter in area were excluded from the total tissue area examined.
Data from two-dimensional measurements of size and number of AHF/sq. centimeter were subjected to three-dimensional (stereologic) analyses as described by Campbell et using the median smoothing method described by Pugh et For these latter estimates, an area of 0.004 sq. millimeter, which is the approximate area of a 10-cell basophilic focus, was judged to be the minimum size at which foci could be reliably identified.
Stereologic data were analyzed to determine the potential effect of leukemia on AHF by comparing AHF in leukemic and non-leukemic animals at the same age. Analysis included Jonckheere's two-tailed procedure to test for an increasing or decreasing trend across groups. Estimates were subjected to hypothesis tests using nonparametric methods.I9
Results
Data on numbers of altered hepatocellular foci (AHF) per cubic centimeter for control rats for the seven studies reported here are summarized in Fig. 1 . What is evident from these data is a progressive increase in the numbers of AHFs over time in non-leukemic rats in contrast to a relative reduction in AHF/cubic centimeter for male and female rats with leukemia at the 24-month study termination. At this time, there is a greater reduction in AHF in rats with more severe leukemia (Fig. 1 ). Since few rats killed at interim time points have leukemia, the comparison ofAHF between non-leukemic and leukemic rats is necessarily limited to the 24-month time point.
AHF were phenotypically similar in leukemic and non-leukemic rats. While all leukemic and non-leukemic rats had AHF, there were significant changes in the incidence of specific types of AHF in the leukemic rats (Table 1 ). In male rats with spontaneous leukemia, there was a significant reduction in basophilic, clear, vacuolated, and mixed-cell AHF and a higher, but not statistically significant, incidence of eosinophilic AHF. Although the trend was essentially similar, changes in the incidences of AHF were less dramatic in females where only clear cell foci were significantly reduced * Significantly different from non-leukemic rats ( P < 0.05).
when leukemia was present. As in the males, there was a non-statistically significant increased incidence of eosinophilic foci in leukemic females. In general, a reduction in the incidence of each type of focus was directly associated with an increased severity of the leukemia as assessed by degree of hepatic infiltration by leukemic cells (Table 1) . Occasionally, regenerative hyperplasia was noted in severely (4+) leukemic rats, particularly in the presence of hepatic parenchymal damage secondary to the leukemia, but such animals were not subjected to stereologic analysis. Despite the fact that all leukemic rats had some AHF, there was a significant reduction in the number of AHF/ cubic centimeter in the rats with leukemia (Table 2) . This decrease in AHF was a consequence of reduced numbers of basophilic, clear, vacuolated, and mixedcell AHF. In contrast, the numbers of eosinophilic AHF were relatively unchanged in leukemic rats. The above effects were directly associated with the severity of the hepatic leukemic infiltrate (Table 2) .
Stereologic analysis of the size (mean volume) of the AHF and the percent of liver occupied (volume fraction) by these AHF revealed that male rats with leukemia had larger basophilic, eosinophilic, and mixedcell AHF (Table 3 ). In leukemic males, the volume fraction of basophilic, eosinophilic, and mixed-cell AHF was greater than in non-leukemic males, while that of clear and vacuolated cell AHF was significantly smaller (Table 3) . In leukemic females, the volume fraction of clear cell AHF was significantly decreased. The increase in mean volume and volume fraction of AHF in leukemic male rats could not be attributed to a dominant effect by any one type of AHF.
Discussion
Mononuclear cell leukemia (synonyms: large granular lymphocytic leukemia, Fischer rat leukemia, monocytic leukemia) is one of the most common neoplasms of Fischer 344 rats12 with an average cumulative incidence of 34% in control males and 209' 0 in control females at 26 months of age.15J6 Rats are typically affected starting at about 18 months of age with a rapid increase in incidence as a function of age. The morphologic, biochemical, and biological features of mononuclear cell leukemia are well described. L5,24, 34 Typically, the disease starts in the spleen, and, ultimately, leukemic cells may infiltrate many tissues. The liver is invariably affected by proliferation of leukemic cells in sinusoidal spaces with ultimate alteration of hepatic architecture. Once leukemic cells begin proliferating in the spleen, the disease runs a short clinical course of 4 to 6 weeks, is associated with a profound anemia, and is invariably fatal. Treatment with specific chemical agents has been associated with marked reductions or increases in the incidence of mononuclear Progressive increases in the number of AHF/cubic centimeter of liver in this study are consistent with a previous report that AHF increase in control Fischer 344 rats as a function of age.3o We also demonstrated a reduction in the number of AHF/cubic centimeter for male and female rats with leukemia at the 24-month cell leukemia. 15,16,22,23.41 termination of the seven National Toxicology Program 2-year studies. At that time, the rats were approximately 26 months old. Such a reduction could only come about by a regression of existing AHF, a blocking in the development of AHF, or an inability to identify AHF in histologic sections from the leukemic rats. We feel confident that identification of AHF was not compromised by concomitant presence of leukemic infiltrates in the livers, since none of the cases selected involved severe liver infiltration by leukemic cells. Given the short clinical course of 4 to 6 weeks for mononuclear cell leukemia in Fischer 344 rats, there is probably insufficient time to prevent the development of a significance number of evolving AHF. Consequently, it is suggested that the most reasonable explanation for the data is that the concomitant presence of mononuclear cell leukemia induces the regression of existing AHF by some unknown mechanism. Regression of existing foci and reduction in liver tumors following cessation of treatment with known hepatocarcinogens has been previously documented.3, 4Jo, [26] [27] [28] [29] 32, 37, 40 Dramatic regression of AHF has also been documented following removal of dietary phenobarbital in studies where this compound is used to promote carcinogen-initiated hepatocytes. *Ox1
The mechanism(s) whereby mononuclear cell leukemia affects the number of AHF in control Fischer 344 rats is presently unknown. Since serum glucose levels are reduced in rats with mononuclear cell leu-kemia,21 the significant reduction in glycogen-storing clear AHF may somehow be related to perturbations in glucose metabolism. Tissue anoxia secondary to the profound anemia associated with mononuclear cell leukemia could also have an impact on the stability of AHF. The fact that the number, size, and volume fraction of eosinophilic AHF in leukemic males does not diminish may reflect a selective growth advantage for these AHF due to the presence of the leukemia and/ or hormonal factors. It is well known that hormonal factors play an important role in development of hepatic neoplasia in male mice,13 although a similar association has not been shown in rats. The quantitative changes in AHF in leukemic Fischer 344 rats may reflect the same unknown processes responsible for the observed negative association between leukemia and liver neoplasia in rodents. 1 s~1 6~2 2 , 2 3 , 3 6 , 4 1 On the basis of the observations reported here, it is recommended that AHF data from leukemic rats be used cautiously in study interpretation by the pathologist and in regulatory decision-making. Because Fischer 344 rats with leukemia have a significant reduction in number, size, and volume fraction of AHF, it may be scientifically prudent to censor Fischer 344 rats with leukemia from any interpretative judgements regarding AHF; furthermore, because regenerative hyperplasia may occur in the livers of severely leukemic rats, it is important that such proliferative lesions not be classified as large AHF. Hepatic degenerative changes are typically associated with regenerative hyperplasia but not with AHF.
